| 000 | 01789 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513100500.0 | ||
| 264 | 0 | _c19961218 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0006-3495 | ||
| 024 | 7 |
_a10.1016/S0006-3495(96)79220-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJoyner, R W | |
| 245 | 0 | 0 |
_aModulating L-type calcium current affects discontinuous cardiac action potential conduction. _h[electronic resource] |
| 260 |
_bBiophysical journal _cJul 1996 |
||
| 300 |
_a237-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xpharmacology |
| 650 | 0 | 4 |
_aAction Potentials _xdrug effects |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiophysical Phenomena |
| 650 | 0 | 4 | _aBiophysics |
| 650 | 0 | 4 |
_aCalcium Channel Agonists _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channels _xdrug effects |
| 650 | 0 | 4 | _aCalcium Channels, L-Type |
| 650 | 0 | 4 | _aElectric Conductivity |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 |
_aHeart Ventricles _xcytology |
| 650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
| 650 | 0 | 4 | _aModels, Cardiovascular |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNifedipine _xpharmacology |
| 700 | 1 | _aKumar, R | |
| 700 | 1 | _aWilders, R | |
| 700 | 1 | _aJongsma, H J | |
| 700 | 1 | _aVerheijck, E E | |
| 700 | 1 | _aGolod, D A | |
| 700 | 1 | _aVan Ginneken, A C | |
| 700 | 1 | _aWagner, M B | |
| 700 | 1 | _aGoolsby, W N | |
| 773 | 0 |
_tBiophysical journal _gvol. 71 _gno. 1 _gp. 237-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0006-3495(96)79220-2 _zAvailable from publisher's website |
| 999 |
_c8799452 _d8799452 |
||